Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.37 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14194247 | 1.00 | ALB (0.51) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL24299247 | 1.00 | ALB (0.51) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL26332859 | 1.00 | ALB (0.51) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL25827327 | 0.88 | ALB (0.41) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL24047298 | 0.88 | ALB (0.41) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL24047242 | 0.88 | ALB (0.41) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL25831639 | 0.88 | ALB (0.41) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL26332856 | 0.82 | ALB (0.35) | ALBLMNACYP2C9 | |
| SCHEMBL20730592 | 0.79 | ALB (0.37) | ALBLMNACYP2C9HTR2AADRA1A | |
| SCHEMBL23836664 | 0.78 | ALB (0.33) | ALBLMNACYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2019032936-A1 | LINCONSAMIDE ANTIBIOTICS AND USES THEREOF | PRESIDENT ADN FELLOWS OF HARVARD COLLEGE (US) | 2019-02-14 | — | — | WO | disclosed |